Clinical Trials Directory

Trials / Completed

CompletedNCT01718314

Comparison of Sublingual Misoprostol Versus Lidocaine Spray for Hysteroscopy

Comparison of Sublingual Misoprostol Versus Lidocaine Spray for Pain Relief in Office Hysteroscopy: A Randomized, Double Blind, Placebo-Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
138 (actual)
Sponsor
Dr. Sami Ulus Children's Hospital · Academic / Other
Sex
Female
Age
18 Years – 51 Years
Healthy volunteers
Not accepted

Summary

Hysteroscopy is an instrument to visualize the interior walls of uterus (womb) and it enables the doctor to do minor operative procedures. Although it causes little discomfort, sometimes it may be disturbing for the patient. This pain is usually perceived during the passage of the instrument through the cervix (neck of the womb). The investigators would like to minimize this pain by two drugs: Misoprotol and lidocaine

Detailed description

Outpatient or office hysteroscopy has become the 'gold standard' for the investigation of the intrauterine abnormalities. This minimal invasive modality provides brilliant and clear visualization of the entire uterine cavity and besides this, by the operative channel, minor procedures may easily be performed in the office setting which is priceless for the gynecologist. However, pain related to the procedure may make the procedure uncomfortable for the patient and the physician. Together with the operative time, hysteroscope diameter is considered as the main factor influencing pain. The pain perceived during hysteroscopy may be reduced by using a smaller diameter hysteroscope or by using anesthesia, which decreases pain perception. In this prospective, randomized, double blind, placebo controlled study, we aim to compare the effectiveness of sublingual misoprostol versus lidocaine pump spray for pain relief during office hysteroscopy.

Conditions

Interventions

TypeNameDescription
DRUGSublingual Misoprostol
DRUGLidocaine pump spray
DRUGPlacebo (for Misoprostol)Lactose filler, the pharmacy-produced pills identical to original misoprostol pill
DRUGPlacebo (for Lidocaine)The pharmacy-produced sterile saline containing pump spray external characteristics identical to lidocaine pump spray

Timeline

Start date
2008-03-01
Primary completion
2009-12-01
Completion
2010-03-01
First posted
2012-10-31
Last updated
2012-10-31

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT01718314. Inclusion in this directory is not an endorsement.

Comparison of Sublingual Misoprostol Versus Lidocaine Spray for Hysteroscopy (NCT01718314) · Clinical Trials Directory